No black box warning on record for Lubiprostone

As of the latest FDA labeling reviewed, Lubiprostone (LUBIPROSTONE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Lubiprostone medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Nausea : Patients may experience nausea; concomitant administration of food may reduce this symptom. ( 2.2 , 5.1 ) Diarrhea : Avoid use in patients with severe diarrhea. Instruct patients to discontinue lubiprostone and contact their healthcare provider if severe diarrhea occurs during treatment. ( 5.2 ) Syncope and Hypotension : May occur after taking the first dose or

No black box warning on record for Lubiprostone

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Nausea : Patients may experience nausea; concomitant administration of food may reduce this symptom. ( 2.2 , 5.1 ) Diarrhea : Avoid use in patients with severe diarrhea. Instruct patients to discontinue lubiprostone and contact their healthcare provider if severe diarrhea occurs during treatment. ( 5.2 ) Syncope and Hypotension : May occur after taking the first dose or

Lubiprostone Black Box Warning

No black box warning on record for Lubiprostone

Other warnings & precautions

Lubiprostone Black Box Warning

No black box warning on record for Lubiprostone

Other warnings & precautions